Blue California (Rancho Santa Margarita, CA) has filed a patent for the therapeutic uses of ergothioneine.
Photo © Shutterstock.com/jovan vitanovski
Blue California (Rancho Santa Margarita, CA) has filed a patent for the therapeutic uses of ergothioneine. This follows the firm’s February 2020 patent application reporting the discovery that ergothioneine inhibits the shortening of telomeres associated with oxidative stress. The most recent patent claims ergothioneine mitigates oxidative stress triggering the inflammatory response in chronic conditions associated with heart disease, diabetes, and cancer.
“Blue California has been at the forefront of research and development regarding ergothioneine using our branded ingredient ErgoActive,” stated Priscilla Samuel, PhD, chief science officer at Blue California, in a press release. “We have found through our research that ergothioneine has tremendous potential to combat oxidative stress and health conditions associated with it.”
Ergothioneine is a naturally-occurring amino acid that comes from a number of dietary sources such as mushrooms. Researchers speculate that ergothioneine is important to human health because we produce a highly specific transport protein called OCTN1 for the amino acid. For its branded ingredient ErgoActive, Blue California received no objection for its GRAS notification from the U.S. Food and Drug Administration. Blue California is the exclusive manufacturer and distributor of ErgoActive for Conagen (Bedford, MA), a biotechnology company with a large portfolio of products for the food, nutrition, and pharma markets.
More research is on the way. “Blue California recently invested in both in vitro and in vivo research of ErgoActive,” said Samuel. “We will be studying how ergothioneine supplementation can support various health benefits, including immune health. We also look forward to clinical studies that further test and demonstrate these novel benefits included in our patent application, and in the emerging scientific literature.”
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
2 Commerce Drive
Cranbury, NJ 08512